Peculiarities of influence of NO-synthase inhibitors on behavioral parameters of rats

Cover Page


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

Aim. A comparative study of the influence of nitric oxide synthase (NO-synthase) inhibitors on the parameters of anxiety, motor activity and pain sensitivity of rats.

Materials and Methods. The work was conducted on male rats of Wistar line. The anxiety level and locomotor activity of rats were studied in the «elevated plus maze» (EPM) test. Pain sensitivity of the animals was tested on the «hotplate» apparatus. In the work, selective inhibitor of inducible isoform of NO-synthase – aminoguanidine – at a dose of 50 mg/kg, and non-selective inhibitor of this enzyme – N-nitro-L-arginine – at a dose of 50 mg/kg, were used. Rats of the control group were introduced the equivalent quantity of normal saline.

NO-synthase inducible inhibitor – aminoguadinine did not produce any influence on the anxiety level, but led to reduction of the horizontal motor activity of rats. Introduction of non-selective NO-synthase inhibitor – N-nitro-L-arginine – was accompanied by reduction of the anxiety and of the locomotor activity of animals in the EPM test. Both investigated NO-synthase inhibitors induced alteration of pain sensitivity of rats in the form of hypoalgesia. Here, the most pronounced nociceptive effect was observed with introduction of non-selective NO-synthase inhibitor.

Conclusion. In the work the evidence of participation of inducible isoform of NO-synthase in realization of the motor activity and pain sensitivity processes in rats is shown. In result of the conducted experiments it was found that introduction of non-selective NO-synthase inhibitor N-nitro-L-arginine was accompanied by evident alterations of anxious behavior, locomotor activity and nociceptive sensitivity of rats. The results obtained confirm the important role of the system of regulation of nitric oxide synthesis in neurochemical mechanisms of behavioral reactions in rats.

Full Text

Restricted Access

About the authors

Valentina G. Bashkatova

Anokhin Scientific Research Institute of Normal Physiology

Author for correspondence.
Email: v.bashkatova@nphys.ru
ORCID iD: 0000-0001-6632-5973
SPIN-code: 7383-8483

PhD in Biological Sciences, Leading Researcher of the Reinforcements Physiology Laboratory

Russian Federation, Moscow

Natalia G. Bogdanova

Anokhin Scientific Research Institute of Normal Physiology

Email: natbog07@yandex.ru
ORCID iD: 0000-0003-2345-8578
SPIN-code: 5580-9324

PhD in Biological Sciences, Senior Researcher of the Reinforcements Physiology Laboratory

Russian Federation, Moscow

Elena V. Alexeeva

Anokhin Scientific Research Institute of Normal Physiology

Email: pravo-nadzor@yandex.ru
ORCID iD: 0000-0001-8488-0508
SPIN-code: 9248-3657

Junior Researcher of the Reinforcements Physiology Laboratory

Russian Federation, Moscow

Galina A. Nazarova

Anokhin Scientific Research Institute of Normal Physiology

Email: g-a-nazarova@rambler.ru
ORCID iD: 0000-0002-7470-1120
SPIN-code: 2506-4688

PhD in Biological Sciences, Senior Researcher of the Reinforcements Physiology Labo-ratory

Russian Federation, Moscow

Sergey K. Sudakov

Anokhin Scientific Research Institute of Normal Physiology

Email: s-sudakov@nphys.ru
ORCID iD: 0000-0002-9485-3439
SPIN-code: 1127-4090

MD, PhD, Professor, Corresponding Member of RAS, Deputy Director for Research, Head of the Reinforcements Physiology Laboratory

Russian Federation, Moscow

References

  1. Moncada S, Bolaños JP. Nitric oxide, cell bioenergetics and neurodegeneration. Journal of Neurochemistry. 2006;97(6):1676-89. doi: 10.1111/j.1471 -4159.2006.03988.x
  2. Garthwaite J. NO as a multimodal transmitter in the brain: discovery and current status. British Journal of Pharmacology. 2019;176(2):197-211. doi:10.1111/ bph. 14532
  3. Philippu A. Nitric oxide: a universal modulator of brain function. Current Medicinal Chemistry. 2016;23(24): 2643-52. doi: 10.2174/0929867323666160627120408
  4. Kikuchi R, Ambe K, Kon H, et al. Nitric oxide synthase (NOS) isoform expression after peripheral nerve transec-tion in mice. The Bulletin of Tokyo Dental College. 2018;59(1):15-25. doi: 10.2209/tdc publication.2017-0007
  5. Fadyukova O.E., Kuzenkov V.S., Koshelev V.B., et al. Semax prevents from the excess nitric oxide production caused by incomplete global ischemia in rat brain. Eksperimental’naya i Klinicheskaya Far-makologiya. 2001;64(2):31-4. (In Russ).
  6. Sharma Sh, Puttachary S, Thippeswamy T. Glial source of nitric oxide in epileptogenesis: a target for disease modification in epilepsy. Journal of Neuroscience Research. 2019;97(11):1363-77. doi:10. 1002/jnr.24205
  7. Tripathy D, Chakraborty J, Mohanakumar KP. Antagonistic pleiotropic effects of nitric oxide in the pathophysi-ology of Parkinson's disease. Free Radical Research. 2015;49(9):1129-39. doi: 10.3109/10 715762.2015.1045505
  8. Gilhotra N, Jain H, Dhingra D. Differential effects of nitric oxide synthase inhibitors on anxiety in unstressed and stressed mice. Indian Journal of Experimental Biology. 2010;48(4):365-72.
  9. Gulati K, Rai N, Ray A. Nitric oxide and anxiety. Vitamins and Hormones. 2017;103:169-92. doi:10. 1016/bs.vh.2016.09.001
  10. Kumar A, Chanana P. Role of nitric oxide in stress-induced anxiety: from pathophysiology to therapeutic target. Vitamins and Hormones. 2017;103:147-67. doi: 10.1016/bs.vh.2016.09.004
  11. Miclescu A, Gordh T. Nitric oxide and pain: 'So-mething old, something new'. Acta Anaesthesiolo-gica Scandi-navica. 2009;53(9):1107-20. doi:10.1111/ j.1399-76.2009.02054.x
  12. Pradhan AA, Bertels Z, Akerman S. Targeted Nitric Oxide Synthase Inhibitors for Migraine. Neuro-therapeutics. 2018;15:391-401. doi: 10.1007/s13311 -018-0614-7
  13. Camargo EA, Santana DG., Silva CI, et al. Inhibition of inducible nitric oxide synthase-derived nitric oxide as a therapeutical target for acute pancreatitis induced by secretory phospholipase A2. European Journal of Pain. 2014;18(5):691-700. doi:10.1002/ j.1532-2149.2013.00414.x
  14. Bashkatova V, Philippu A. Role of nitric oxide in psychostimulant-induced neurotoxicity. AIMS Neuroscience. 2019;6(3):191-3. doi: 10.3934/Neuroscience. 2019.3.191
  15. Pellow S, Chopin P, File E, et al. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. Journal of Neuroscience Methods. 1985;14(3):149-67. doi:10.1016/ 0165-0270(85)90031-7
  16. Bondarenko DA, Dyachenko IA, Skobtsov DI, et al. In vivo models of studying of analgetic activity. Biomedi-cine. 2011;(2):84-94. (In Russ).
  17. Celik T, Zagli U, Kayir H, et al. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug and Alcohol Dependence. 1999; 56(2):109-13. doi: 10.1016/s0376-8716 (99)00031-9
  18. Joung HY, Jung EY, Kim K, et al. The differential role of NOS inhibitors on stress-induced anxiety and neuroen-docrine alterations in the rat. Beha-vioural Brain Research. 2012;235(2):176-81. doi:10. 1016/j.bbr.2012.07.037
  19. Cinelli MA, Do HT, Miley GP, et al. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Medic-inal Research Reviews. 2020;40(1): 158-89. doi: 10.1002/med.21599

Supplementary files

Supplementary Files
Action
1. JATS XML
2. Fig. 1. Effect of NO-synthase inhibitors on the time of stay of rats in the open arms (sec) in EPM test

Download (65KB)
3. Fig. 2. Effect of NO-synthase inhibitors on motor activity (conv. un.) of rats in EPM test

Download (67KB)
4. Fig. 3. Effect of NO-synthase inhibitors on the latent period of licking paws (sec) in «hot plate» test

Download (79KB)

Copyright (c) 2020 Eco-Vector


Media Registry Entry of the Federal Service for Supervision of Communications, Information Technology and Mass Communications (Roskomnadzor) PI No. FS77-76803 dated September 24, 2019.



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies